Podcasts about Influenza

Ian Barr, Deputy Director of the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne

Nos últimos anos, surtos de contaminação com o vírus H5N1 vem se espalhando pelo globo, e se aproximando cada vez mais do Brasil. O país, que nunca registrou sinais de gripe aviária em granjas, identificou dois casos em aves silvestres no Espírito Santo; desde então, novos focos apareceram. São 13 até agora - além do Espírito Santo, Rio de Janeiro e Rio Grande do Sul também têm casos. Para mensurar o risco que a doença oferece, Natuza Nery fala com Paula Salati, repórter de agro do g1, e com o economista Fernando Henrique Iglesias, analista e consultora da Safras & Mercado. Neste episódio: - Paula explica as características do vírus H5N1, um subtipo do Influenza que afeta predominantemente as aves. Ele foi detectado pela primeira vez em 1996, na China, onde também foi registrado o primeiro contágio humano – nos últimos anos, tem se disseminado pelas Américas. “É um vírus que se espalha rapidamente e tem alta taxa de mortalidade”, afirma; - A jornalista justifica a decisão do Ministério da Agricultura de decretar estado de emergência zoossanitária: “A principal preocupação é evitar que a gripe chegue às granjas”. Caso haja contaminação nos produtores dedicados ao comércio de carnes e ovos, é preciso sacrificar todas as aves, explica; - Fernando dimensiona o tamanho do mercado de aves no Brasil: segundo maior produtor do mundo, maior exportador e prevê a produção de 15 milhões de toneladas de carne de frango até o fim do ano. E ressalta que, embora “o Brasil siga os mais rigorosos protocolos sanitários animais”, o mercado pode sofrer um baque caso a gripe chegue às granjas comerciais; - Ele também comenta o impacto da crise zoossanitária na Europa e nos Estados Unidos, onde houve desabastecimento e boom inflacionário na comercialização de ovos. No Brasil, avalia, “será preciso ter um descontrole muito grande” para que a inflação geral de preços seja pressionada.

You've had the flu. You've had a cold. Maybe you've even had allergies! But how can you tell them apart? And if you even figure out that you do have influenza, are there any treatments you can take that can help? References: https://www.health.harvard.edu/staying-healthy/gastroenteritis-in-adults-a-to-z https://academic.oup.com/aje/article/182/4/294/113092 https://onlinelibrary.wiley.com/doi/full/10.1111/irv.12515 https://www.cdc.gov/flu/about/burden/preliminary-in-season-estimates.htm https://newsinhealth.nih.gov/2014/10/cold-flu-or-allergy https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0000221 https://www.cdc.gov/mmwr/volumes/71/wr/mm7150a4.htm https://www.mobihealthnews.com/news/lucira-health-files-bankruptcy-it-receives-eua-home-covid-19-flu-test https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-over-counter-home-test-detect-both-influenza-and-covid-19-viruses https://www.nature.com/articles/s41598-019-39683-4 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108042/ https://www.cdc.gov/flu/treatment/antiviralresistance.htm https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404498/ https://www.mdpi.com/2076-2607/11/1/183 https://www.jbc.org/article/S0021-9258(21)00260-X/fulltext

In his weekly clinical update, Dr. Griffin discusses the CDC HIV surveillance report, FDA voted in favor of approving the Abrysvo vaccine, canine olfactory detection of SARS-CoV-2-infected humans, safety of the BNT162b2 COVID-19 vaccine in children aged 5 to 17 years, and statement on the antigen composition of COVID-19 vaccines. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode HIV surveillance report (CDC) FDA voted in favor of approving Abrysvo vaccine (Pfizer) Canine olfactory detection of SARS-CoV-2-infected humans (Annals of Epidemiology) Safety of the BNT162b2 COVID-19 vaccine in children (JAMA) Statement on the antigen composition of COVID-19 vaccines (WHO) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1010 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

-Suministro de agua potable se verá afectado en Xochimilco-Roban 250 dosis contra la influenza en Perú-Más información en nuestro podcast

Episode #065 Amid the laughter and humor, that has not changed since they were last heard from before the Holidays. Our hosts discuss where they have been and why they have been gone for so very long. Right when Thanksgiving hit, they were preparing for the Holiday break, cooking, baking, Christmas shopping and mailing out gifts and baked goods. And then came black Friday or possibly the black plague for the two of them. They both went down with covid, Patrick added the flu, Influenza type A. Janet added Bronchitis to hers. This is when they discovered what people do not advertise or talk about. Anything that has ever gone wrong with you will rear its head again after covid hits you. So, the Holidays were exciting in an all new way for them this year and baking and dinner went out the door.With the time on their hands, they began talking more about where to take this podcast to, going on year 4. It began as trucking, then they tried expanding it for a while. Which simply put, was ok, but not where their hearts are at. So, they both decided the only way to go was back to their roots, yep, Trucking. However, this time they chose to do more research prior to recording anything. As well as finding a way to help others while they still talk about trucking.Those thoughts being said aloud, they began with notes, lots of notes. Enough for about 70 or more episodes! Beginning to seasoned veteran drivers, they desire to help all of them. And with the direction they are headed, and the notes they have, it is very likely that they will.From learning about the new ways and listening to the old ways and the stories of how things used to be. The good and the bad on both, then this is the Trucking Podcast for you. 40+ years' experience and hauled just about everything between them. Look for them doing industry interviews, coming to Truck shows, their new fan club, social media contests, and more!We will catch you on the flip side!Full podcast show notes available here:  https://www.18wheeltalk.com/e65Omalight Flashlight Military-grade aluminum alloy as the body material. It's also shockproof, dirtproof, waterproof, snow proof and shall we say it....Trucker Proof.Amazon Associate The world's largest online retailer and a prominent cloud service provider. Buzzsprout - Let's get your podcast launched! Start for FREE Patreon Subscription Service A membership tool for creators and artists to earn money by providing rewards & perks to subscribersCLX Gaming PC - Game like the pros! Bring your gaming to the next level. ** With financing available from Affirm & Katapult.**Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showThanks for listen. Be sure to look us up on Social Media @18wheeltalk on everything.

Last episode we discussed the current H5N1 flu that is hitting birds pretty hard. But is bird flu different from swine flu? Is there just a 'human flu', or do we only catch influenza from other animals? Let's get into the evolutionary history of the flu and primary hosts! References: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328453/ https://www.ncbi.nlm.nih.gov/books/NBK8611/ https://journals.asm.org/doi/full/10.1128/JVI.01080-14 https://www.cdc.gov/flu/weekly/index.htm https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268205/ https://www.woah.org/en/disease/avian-influenza/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784916/ https://www.frontiersin.org/articles/10.3389/fevo.2018.00131/full https://www.science.org/doi/10.1126/science.1176225 https://pubmed.ncbi.nlm.nih.gov/32967956/

Vincent travels to Montreux, Switzerland and the 16th International Nidovirus Symposium, where he speaks with Maria von Kerkhove, the face of COVID-19 for the World Health Organization, and Kanta Subbarao, Director of the WHO Collaborating Centre on Influenza in Melbourne. Host: Vincent Racaniello Guests: Kanta Subbarao and Maria von Kerkhove Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode MicrobeTV Discord Server Nidovirus Symposium, Montreux WHO Collaborating Centre for Influenza, Melbourne Maria von Kerkhove (Wikipedia) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

In his weekly clinical update, Dr. Griffin discusses variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC, ventilation in buildings, COVID-19 mortality among selective serotonin reuptake inhibitor users, risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses, trajectories of the evolution of post COVID-19 condition, and efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Virus variant clinical performance of a SARS-CoV-2 rapid antigen test (CID) Ventilation in buildings (CDC) COVID-19 mortality among SSRI users (CMI) Risk of post-acute sequelae of SARS-CoV-2 infection associated with sleep apnea (SLEEP) Trajectories of the evolution of post COVID-19 condition (IJID) Efficacy of cognitive behavioral therapy targeting fatigue following COVID-19 (CAD) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1008 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Dr. Lee Merritt joins the show to share with listeners the unknown history of the Spanish Flu and the flu in general. We discuss frequency energy and how our bodies are batteries highly effected by frequency, EMF and the sun's energy.You can learn more about Dr. Lee Merritt at https://www.drleemerritt.com/Follow on my Substack at SarahWestall.Substack.com

In his weekly clinical update, Dr. Griffin discusses immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age, influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults, COVID-19 surveillance after expiration of the public health emergency declaration, provisional mortality data, targeted vaccine messaging to promote COVID-19 vaccines for children and youth, vaccines and related biological products advisory committee meeting June 15, 2023 announcement, how to overhaul the CDC, impact of SARS-CoV-2 variants on inpatient clinical outcome, prevalence of post-coronavirus disease condition 12 weeks after Omicron infection compared with negative controls and association with vaccination status, gut bacteria cocktail helps long COVID, and gut microbiota‐derived symbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Immunogenicity and tolerability of a bivalent norovirus vaccine in children (HVI) Influenza hemagglutinin stem nanoparticle vaccine induces neutralizing antibodies in healthy adults (STM) COVID-19 surveillance after expiration of the public health emergency declaration (CDC) Provisional mortality data (CDC) Targeted messaging to promote COVID-19 vaccines for children and youth (Pediatrics) Vaccines and biological products advisory committee meeting announcement (FDA) How to overhaul the C.D.C (NYTIMES) Impact of SARS-CoV-2 variants on inpatient clinical outcome (CID) Prevalence of post-COVID19 condition 12 weeks after Omicron infection and vaccination status (CID) Gut bacteria cocktail helps long COVID (MedPage) Gut microbiota‐derived synbiotic formula as a therapy for COVID‐19 (NIH) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1006 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

He is an evidence-based opinion journalist who focuses on the Global Pandemic & the 2017 Las Vegas Shooting. He is incognito, wearing a hat, sunglasses and goes by the alias John Cullen. We discuss why did Influenza disappear in early 2020.   Let me know what you think Text me 587-217-8500 SNP Presents: Luongo & Krainer https://www.showpass.com/snp-presents-luongo-krainer/ Substack: https://open.substack.com/pub/shaunnewmanpodcast

Influencers often inspire or guide the actions of others by posting about something (such as a consumer product or service) that they use or endorse based on brand partnerships. And today's episode is a sure shot response to Sue Duffield's recent "Effector" award of Top Influencer, but what she initially read was "Influenza!" The most all-inclusive definition of an influencer is a person who has the ability to influence others. So, a politician making a speech, a business expert leading a seminar, and a celebrity endorsing a product are all technically influencers, and yes even pastors, singers and keynote speakers. An infectious personality, like Sue, may know a lot, but an individual still needs the ability to advocate, sell and drum up enthusiasm. Influencers normally have high engagement rates with their audience (in person or on-line), taking on a hands-on approach with their people, showing great care, and always looking to serve their needs to better understand them. So, just how important is it to be an effective influencer for the Kingdom's sake? Everything. Let Jesus shine SO much in your life that you're infectious and that you get reports of your influence - from all generations. www.sueduffield.com

SwineCast 1232 Show Notes: Dr. Steve Meyer (Lead Economist, Partners for Production Agriculture) joins the At The Meeting team to discuss the outlook for current low pig prices. Lower demand and increasing costs will make 2023 a difficult year, but Meyer says it is important to remember the advantages U.S. pork producers enjoy. On ‘At …

In his weekly clinical update, Dr. Griffin discusses the U.S. Food and Drug Administration approving Arexvy: the first respiratory syncytial virus (RSV) vaccine approved for use in the United State, association between SARS-CoV-2 and metagenomic content of samples from the Huanan Seafood Market, researchers disagree over how bad it is to be reinfected and whether COVID-19 can cause lasting changes to the immune system, virtual care and emergency department use during the COVID-19 pandemic among patients of family physicians in Canada, vaccination with BCG-Denmark did not result in a lower risk of COVID-19 among health care workers than placebo, NVX-CoV2373 vaccine efficacy against hospitalization, comparative effectiveness of the SARS-COV-2 vaccines during Delta dominance, assessment of gender-specific COVID-19 case fatality risk per malignant neoplasm type, clinical outcomes following treatment for COVID-19 with Nirmatrelvir/Ritonavir and Molnupiravir among patients living in nursing homes, timing of intubation and ICU mortality in COVID-19 patients, real-life experience with Remdesivir for treatment of COVID-19 among older adults, and how long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode FDA approves Arexvy, the first RSV vaccine approved in the US (FDA) Association between SARS-CoV-2 and content of samples from the Huanan Seafood Market (bioRxiv) Researchers disagree over how bad it is to be reinfected with COVID-19 and lasting changes to the immune system (Nature) Virtual care and emergency department use during the COVID-19 Pandemic among patients of family physicians (JAMA) Vaccination with BCG-Denmark did not result in a lower risk of COVID-19 among health care workers (NEJM) NVX-CoV2373 vaccine efficacy against hospitalization (Vaccine) Comparative effectiveness of the SARS-COV-2 vaccines during Delta (Cell) Assessment of gender-specific COVID-19 case fatality risk (JAMA) Clinical outcomes following treatment for COVID-19 with Nirmatrelvir/Ritonavir and Molnupiravir (JAMA) Timing of intubation and ICU mortality in COVID-19 patients (BMC) Real-life experience with Remdesivir for treatment of COVID-19 (JAC) Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA (Frontiers) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1004 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

On episode #27 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the previous two weeks, 4/13 – 4/25/23. Hosts: Daniel Griffin and Sara Dong Click arrow to play Download Puscast 027 (19 MB .mp3, 31 min) Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of Puscast! Links for this episode Prevalence, clinical severity, and seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus among children with moderate-to severe diarrhea (CID) Antibiotic-prescribing practices for management of childhood diarrhea in 3 sub-Saharan African countries (CID) Drivers of decline in diarrhea mortality (CID) Breastfeeding among people with HIV in North America (CID) Wearable sensor-based detection of Influenza in presymptomatic and asymptomatic individuals (JID) Emergence of erythromycin-resistant invasive group a Streptococcus (EID) Piperacillin-Tazobactam compared With Cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy (JAMA) VE303 for prevention of recurrent Clostridioides difficile infection (JAMA) Geographic patterns of antimicrobial susceptibilities for Bacteroides species worldwide (IJAA) Intravenous to oral antibiotic switch therapy among patients hospitalized with community-acquired pneumonia (CID) Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalized with suspected gastroenteritis (The Lancet) Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (Mycoses) Giardia detection and codetection with other enteric pathogens in children in the vaccine impact on diarrhea in Africa (CID) Feasibility of training community health workers to use smartphone-attached microscopy for point-of-care visualization of soil-transmitted helminths (AJTMH) Compassionate use of bacteriophages for failed persistent infections (OFID) Music is by Ronald Jenkees

In his weekly clinical update, Dr. Griffin discusses completeness and spin of medRxiv preprints and associated published abstracts of COVID-19 randomized clinical trials, lessons learned from a COVID-19 dog screening pilot in California K-12 schools, SARS-CoV-2 reinfection and severity of the disease, effectiveness of COVID-19 bivalent vaccine, Molnupiravir and risk of post-acute sequelae of COVID-19, risk of new-onset long Covid following reinfection with SARS-CoV-2, low vitamin D levels associated with long COVID syndrome in COVID-19 survivors, and clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”. Click arrow to play Download TWiV 1002 (27 MB .mp3, 44 min) Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Completeness and spin of medRxiv preprint and published abstracts of COVID-19 randomized clinical trials (JAMA) Lessons learned from a COVID-19 dog screening pilot (JAMA) SARS-CoV-2 reinfection and severity of the disease (Viruses) Effectiveness of COVID-19 bivalent vaccine (medRxiv) Molnupiravir and risk of post-acute sequelae of COVID-19 (BMJ) Risk of new-onset long Covid following reinfection with SARS-CoV-2 (medRxiv) Low vitamin D levels are associated with Long COVID in COVID-19 survivors (JCEM) Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for treatment of Long-COVID19 (NIH) Contribute to our ASTMH fundraiser at PWB Letters read on TWiV 1002 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Today, Debbie re-runs the single most popular of 100+ episodes of [B]OLDER. Exactly two years ago, in the spring of 2021, she asked plague expert Nicholas Christakis, a distinguished Yale professor and author,  the burning question: when will the COVID-19 pandemic end? His answer: 2024. It startled her and burst her bubble of optimism. Vaccines were widely available by then and it seemed like the beginning of the end. Surely he was exaggerating how long it would take for the COVID pandemic to wind down? No, it was only the end of the beginning, he told her.Today that makes sense. And of course, it was prescient.Tune into a re-run of one of the most fascinating episodes of [B]OLDER. (Note that Debbie refers to it as The Gap Year Podcast, the name she gave the podcast during the height of the pandemic. It's now the [B]OLDER podcast. Same podcast; different name.) SHOW NOTES from the original interview with Nicholas Christakis (May 7, 2021)Nicholas Christakis, MD, PhD, MPH, and a Sterling Professor at Yale, has been named to TIME magazine's list of the 100 Most Influential People in the World. His fluency in explaining the intertwined science, epidemiology, psychology, sociology and history of pandemics - and his sense of humor - make this a compelling episode. You'll hear why he chose to publish his latest book, Apollo's Arrow, in the fall of 2020, before we knew the end of the story of COVID-19How his childhood experiences with illness and death affected his career choicesWhat the predictable three phases of a pandemic are (in 2021 we were still in the immediate phase)Why he thinks this pandemic won't be over until 2024They also talked about separating the biological vs. the psychological impacts of the pandemicWhat herd immunity actually means and whether we'll get thereAnd what the public health messaging around the pandemic should beDebbie asks him point blank: when is the next pandemic? The answer is unnerving – sooner than you might think. About Nicholas ChristakisWikipediaTwitterYale UniversityTed TalksHuman Nature Lab at Yale Books by Nicholas ChristakisApollo's Arrow: The Profound and Enduring Impact of Coronavirus on the Way We Live by Nicholas Christakis (Little, Brown Spark 2020)Blueprint: The Evolutionary Origins of a Good Society by Nicholas Christakis (Little, Brown Spark 2019)Connected: The Surprising Power of Our Social Networks and How They Shape Our Lives by Nicholas Christakis (Little, Brown Spark 2009)Death Foretold: Prophecy and Prognosis in Medical Care by Nicholas Christakis (University of Chicago Press, 2001) Articles and interviewsThe New York Times Book Review: The Pandemic's Future — and Ours (NYT Book Review of Apollo's Arrow, November 3, 2020)A year of COVID: Making sense of an ‘alien and unnatural' time (Yale News, March 4, 2021)Epidemiologist looks to the past to predict second post-pandemic ‘roaring 20s' (The Guardian, December 21, 2020)Denial And Lies Are ‘Almost An Intrinsic Part Of An Epidemic,' Doctor Says (NPR, October 29, 2020)The pandemic is as much about society, leaders, and values as it is about a pathogen (Science Mag, November 17, 2020)The Importance of Being Little: What Young Children Really Need from Grownups by Erika Christakis (Penguin Books 2016)Remote Learning Isn't the Only Problem With School (The Atlantic, December 2020)The COVID-19 Pandemic and the $16 Trillion Virus by Larry H. Summers, PhD and David M. Cutler, PhD (October 12, 2020) Mentioned or usefulThe Plague by Albert Camus (1947)What Is R-naught? Gauging Contagious Infections (Healthline, April 20, 2020)What is Epidemiology?What is Sociology? PHOTO CREDIT: Evan Mann Get the inside skinny on every episode of [B]OLDER:Subscribe to Debbie's newsletter for the inside story about every episode. You will also get her 34-page writing guide: https://bitly.com/debbie-free-guide.   Request from Debbie:If you've been enjoying the podcast, please take a moment to leave a short review on Apple Podcasts. It really makes a difference in attracting new listeners. Connect with Debbie:debbieweil.com[B]OLDER podcastEmail: thebolderpodcast@gmail.comBlog: Gap Year After SixtyFacebook: @debbieweilInstagram: @debbieweilLinkedIn: linkedin.com/in/debbieweilTwitter: @debbieweil Our Media Partners:CoGenerate (formerly Encore.org)MEA and with thanks to Chip ConleyNext For Me (former media partner and in memory of Jeff Tidwell) How to Support this podcast:Leave a review on Apple PodcastsSubscribe via Apple Podcasts, Google Podcasts, Stitcher or Spotify Credits:Host: Debbie WeilProducer: Far Out MediaMusic: Lakeside Path by Duck Lake   

An Interview with Ambassador Nancy Jo Powell by Pranav Guntupalli Interview Summary : Ambassador Nancy Jo Powell speaks about the history of US relations with South Asia including the death of American ambassador Arnold Raphel in 1988, nuclear tension in the subcontinent, and re-emerging non-alignment in India's foreign policy today. She also recounts her experience in the foreign service and shares advice for aspiring diplomats. Biography: Ambassador Nancy Jo Powell is one of the most distinguished diplomats in modern American history. Ambassador Powell joined the foreign service in 1977, and served with distinction for over 37 years, including assignments as the US ambassador to Uganda, US ambassador to Ghana, US ambassador to Pakistan, US ambassador to Nepal, and as the first female US ambassador to India. In 2006, Amb. Powell received one of the US government's most prestigious awards – The Homeland Security service to America award – for her work as the State Department's senior coordinator on the Avian and Influenza epidemics. Amb. Powell holds the rank of Career Ambassador, the highest rank in the US foreign service.

This edition features stories on the H1N1 flu virus vaccine coming to more bases soon, the new Air Force fleece outer garment, and a Pacific Air Force (PACAF) Water Treatment Specialist, or plumber, Airmen continuing to help the people of Indonesia after natural disasters there have rendered many in need of assistance. Hosted by Senior Airman Brad Sisson.

In his weekly clinical update, Dr. Griffin discusses an update on vaccine-derived poliovirus outbreaks, how the dream of wiping out polio might need a rethink, risk of death in patients hospitalized for COVID-19 vs seasonal Influenza in fall-winter, French Mpox cluster includes fully vaccinated patients, two individuals with potential Mpox virus reinfection, epidemiologic and clinical features of Mpox-associated deaths, FDA authorizes changes to simplify use of bivalent mRNA COVID-19 vaccines, SARS-CoV-2 during Omicron variant predominance among infants born to people with SARS-CoV-2, severe maternal morbidity and mortality of pregnant patients with COVID-19 infection during the early pandemic period in the US, sickness presenteeism in healthcare workers during the COVID-19 pandemic, ventilation improvements among k–12 public school districts, risk factors and vectors for SARS-CoV-2 household transmission, SARS-CoV-2 neutralizing antibodies after bivalent versus monovalent, durability of bivalent boosters against Omicron subvariants, Nirmatrelvir and risk of hospital admission or death in adults with COVID-19, evolving real-world effectiveness of monoclonal antibodies for treatment of COVID-19, effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19, efficacy and safety of Anakinra plus standard of care for patients with severe COVID-19, higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support, risk of autoimmune diseases in patients with COVID-19, definition of post–COVID-19 condition among published research studies, and sleep disturbance severity and correlates in post-acute sequelae of COVID-19.  Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Update on vaccine-derived poliovirus outbreaks (CDC) The dream of wiping out polio might need a rethink (NPR) Risk of death in patients hospitalized for COVID-19 vs influenza (JAME) French mpox cluster includes fully vaccinated patients (CIDRAP) Two individuals with potential Monkeypox reinfection (The Lancet) Epidemiologic and clinical features of Mpox-associated deaths (CDC) FDA authorizes changes to simplify use of Bivalent mRNA COVID-19 vaccines (FDA) Omicron variant predominance among infants born to people with SARS-CoV-2 (Pediatrics) Severe maternal morbidity and mortality of pregnant patients with COVID-19 (JAMA)  Sickness presenteeism in healthcare workers during the COVID-19 pandemic (ICHE) Ventilation improvements among K–12 public school districts (CDC) Risk factors and vectors for SARS-CoV-2 household transmission (The Lancet) SARS-CoV-2 neutralising antibodies after bivalent vs monovalent (The Lancet) Durability of bivalent boosters against Omicron subvariants (NEJM) Nirmatrelvir and risk of hospital admission or death in adults with COVID-19 (BMJ) Real world effectiveness of Monoclonal Antibodies for treatment of COVID-19 (AIM) Study on ACE inhibitor and ARB effect on COVID-19 patient outcomes (JAMA) Efficacy and safety of Anakinra plus standard of care for patients with severe COVID-19 (JAMA) High-dose corticosteroids in non-ventilated COVID-19 patients with hypoxia (The Lancet) Risk of autoimmune diseases in patients with COVID-19 (eClinical) Definition of post–COVID-19 condition (JAMA) Sleep disturbance severity and correlates in Post-acute Sequelae of COVID-19 (JGIM) Contribute to our ASTMH fundraiser at PWB Letters read on TWiV 1001 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

SwineCast 1231 Show Notes: SwineCast 1231 Show Notes: “Doing what we know how to do” is the best next step in efforts to eliminate PRRSv from the U.S. herd. The At The Meeting team presents a clear agenda in its continuing conversation with Dr. Scott Dee (Retired Director of Applied Research, Pipestone Veterinary Services) and …

God painted His heart for the Nations throughout the pages of His Word, from Genesis to Revelation... If we live our lives, spend our money, eat/drink, exercise, pray, and practice medicine without catching this vision, we're missing out on the greatest masterpiece ever created! We create a false dichotomy of domestic healthcare and that which is international. God doesn't see it this way and neither should we.

In this episode, we define public health emergency and the end of the State of Emergency and what does that mean for the rest of us in the country.  We talk about what that means for vaccines, medications, masks, the Emergency Use Authorizations or EUA, mandates, keeping our children and other vulnerable family members safe, insurance and what will be available for managing infection with this Emergency Declaration coming to an end.ReferencesWHO . Glossary of Humanitarian Terms. World Health Organization (2008). Available online at: https://www.who.int/hac/about/definitions/en/ What Happens When COVID-19 Emergency Declarations End? Implications for Coverage, Costs, and Access https://www.kff.org/coronavirus-covid-19/issue-brief/what-happens-when-covid-19-emergency-declarations-end-implications-for-coverage-costs-and-access/Influenza data April 12, 2023https://cdc.gov/flu/weekly/indexCovid data, April 12, 2023https://covid.cdc.gov/covid-data-tracker/#trends_weeklydeaths_select_57 Please check out Shared Harvest Fund and their #heartwork:https://sharedharvestfund.com/index.phpSend us your questions and comments to DrToniandDrAimee@gmail.com

Implantable device approved for those with knee osteoarthritis; Prescribing Information labeling updated for opioids; Imbruvica indications withdrawn; Patch to combat excessive underarm sweating given green light; Novel treatment Fast Tracked for Type A and B influenza.

041423 5 Minute CLip Melissa On Influenza Did You Know This by Kate Dalley

In his weekly clinical update, Dr. Griffin discusses the White House COVID adviser calling on doctors to combat a vacuum of medical information, adeno-associated virus type 2 in US children with acute severe hepatitis, genomic investigations of unexplained acute hepatitis in children, surveillance of SARS-CoV-2 at the Huanan seafood market, vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Canada, effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5–17, prevalence and characteristics associated with post–COVID-19 condition among non-hospitalized adolescents and young adults, within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals, live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters, Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2, COVID-19 convalescent plasma utilization in the United States, FDA authorizes Gohibic (vilobelimab) injection for the treatment of COVID-19, anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO), anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19, triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients, and the breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of long COVID symptoms. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode White House COVID adviser calls on doctors to combat medical information (STAT) Adeno-associated virus type 2 in US children with acute severe hepatitis (Nature) Genomic investigations of unexplained acute hepatitis in children (Nature) Surveillance of SARS-CoV-2 at the Huanan Seafood Market (ChinaXiv) Vaccine effectiveness against hospitalization among pediatric SARS-CoV-2 cases (PLOS) Effectiveness of BNT162b2 after extending the series dosing interval in children (Nature) Prevalence and characteristics associated with post–COVID-19 condition (JAMA) Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals (Nature) Replication-competent-attenuated vaccine sCPD9 elicits immunity to SARS-CoV-2 variants (Nature) Fc-γR antibody functions needed for SARS-CoV-2 variant protection via vaccination (Nature) COVID-19 convalescent plasma utilization in the United States (CID) FDA authorizes Gohibic injection for the treatment of COVID-19  (FDA) IFX-1 antibody vs. supportive care for severe COVID-19 patients (Lancet) Vilobelimab therapy for COVID-19 critically ill patients on mechanical ventilation (Lancet) Triple combo therapy for relapsed SARS-CoV-2 in immunocompromised patients with antivirals and antibodies (CID) Neutralizing antibody response breadth to SARS-CoV-2 tied to Long COVID presence (medRxiv) Neurological Long COVID pathogenesis and potential therapies (Journal Cells) Contribute to our ASTMH fundraiser at PWB Dr. Griffin's treatment guide (pdf) Letters read on TWiV 998 Don't crush Paxlovid (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

SwineCast 1230 Show Notes: Decades of hard work have produced a wide assortment of tools to fight the spread of PRRSv. Success and failure and no silver bullets have discouraged many – leaving the impression that the PRRSv cannot be eliminated. The At The Meeting team documents how far the pig industry has come with …

Despite a significant uptick in flu cases this year already, new research shows that people in Australia are not too concerned about catching the virus. With thousands of cases already recorded so far in 2023, and an earlier influenza season likely, experts are advising Australians to start preparing now. - Այս տարի, հակառակ հարբուխի դէպքերու բազմացումին, նոր հետազօտութիւն մը ցոյց կ'ուտայ որ Աւստրալիոյ մէջ մարդիկ շատ մտահոգուած չեն հարբուխով վարակուելէ:

In his weekly clinical update, Dr. Griffin discusses how antibiotics don't reduce risk of death from viral respiratory infections, norovirus infections continue to rise in the US, ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample, maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization, association of treatment with Nirmatrelvir and the risk of Post–COVID-19 condition, mechanically ventilated patients with COVID-19 had a higher chance of in-hospital death if treated with high-flow nasal cannula oxygen before intubation, high-flow nasal cannula and outcomes in COVID-19, severe infection and risk of Cardiovascular disease, and the risk factors associated with post−COVID-19 condition. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Antibiotics don't reduce risk of death from viral respiratory infections (CIDRAP) ABO blood types and SARS-CoV-2 infection (Nature) Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization (Nature Medicine) Association of treatment with Nirmatrelvir and risk of post–COVID-19 (JAMA) Ventilated patients with COVID-19 had a higher chance of in-hospital death with usage of nasal cannula oxygen (IARS) High-flow nasal cannula and outcomes in COVID-19 (IARS) Severe infection and risk of cardiovascular disease (AHA) Risk factors associated with post−COVID-19 condition (JAMA) Contribute to our ASTMH fundraiser at PWB Dr. Griffin's treatment guide (pdf) Letters read on TWiV 996 Don't crush Paxlovid (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

SwineCast 1229 Show Notes: Dr. Carmen Alonso (Boehringer Ingelheim Integrated Health Management) and Dr. Dale Polson (Boehringer Ingelheim Integrated Health Management) share how continuous technology monitoring (collecting various data elements like audio via SoundTalks) can identify sick pigs before humans can identify them.

¡Que no se te pase! continúa Campaña Nacional de vacunación contra Influenza EstacionalBritánicos ahorran ingiriendo comida caducada, afirma la ONS

Despite a significant uptick in flu cases this year already, new research shows that people in Australia are not too concerned about catching the virus. With thousands of cases already recorded so far in 2023, and an earlier influenza season likely, experts are advising Australians to start preparing now. - Несмотря на значительный всплеск случаев заболевания гриппом, наблюдающийся уже сейчас, люди в Австралии, согласно новому исследованиию, не слишком беспокоятся по поводу вируса. Более 15 тысяч случаев заболевания гриппом уже зафиксировано в этом году, и сезон гриппа, вероятно, начнется раньше, поэтому эксперты советуют австралийцам начать подготовку уже сейчас.